MANAGEMENT STOCKHOLDERS AGREEMENT (SENIOR MANAGEMENT FORM)

Exhibit 10.1

MANAGEMENT STOCKHOLDER’S AGREEMENT
(SENIOR MANAGEMENT FORM)

Oncor Management Investment LLC
Oncor Electric Delivery Company LLC

          This Management Stockholder’s Agreement (this “Agreement”) is effective as of November 5, 2008 among Oncor Management Investment LLC (the “Company”), a Delaware limited liability company, Oncor Electric Delivery Company LLC, a Delaware limited liability company (“Oncor”), and the undersigned person (the “Management Stockholder”) (the Company, Oncor and the Management Stockholder being hereinafter collectively referred to as the “Parties”). All capitalized terms not immediately defined are hereinafter defined in Section 7(b) of this Agreement.

          WHEREAS, the Management Stockholder has been selected by the Company and Oncor (i) to be permitted to transfer to the Company cash in exchange for Class B Membership Interests (the “Management Units”) in the Company (the “Cash Purchased Units”); and/or (ii) to be permitted to designate certain funds held pursuant to the EFH Salary Deferral Plan (the “Program”) as deemed to be invested in Management Units (any Management Units issuable to a Management Stockholder Entity (as defined below) pursuant to a distribution under the terms of the Program, “Deferred Purchased Units” and together with the Cash Purchased Units, “Purchased Units”), such Purchased Units issued pursuant to the terms set forth below and the terms of the 2008 Equity Interests Plan for Key Employees of Oncor Delivery Company LLC and its Affiliates; and/or (iii) has been selected by Oncor to receive the right to certain payments from Oncor corresponding to appreciation of the Oncor Units (the “Stock Appreciation Rights”) pursuant to the terms set forth below and the terms of the Oncor Electric Delivery Company LLC Stock Appreciation Rights Plan (the “Stock Appreciation Rights Plan”) and the Award Letter to be entered into by and between Oncor and the Management Stockholder on or about the date hereof (the “Stock Appreciation Rights Agreement”);

          NOW THEREFORE, to implement the foregoing and in consideration of the mutual agreements contained herein, the Parties agree as follows:

          1. Issuance of Purchased Units and Stock Appreciation Rights.

          (a) Subject to the terms and conditions hereinafter set forth, the Management Stockholder hereby subscribes for and shall purchase, as of the date hereof, and the Company shall issue and deliver to the Management Stockholder as of the date hereof, the number of Purchased Units, in each case as set forth on Schedule I hereto at a $10.00 per unit purchase price (the “Base Price”), which Base Price is equal to the effective per unit fair market value of the Purchased Units, taking into account the concurrent issuance of membership interests in Oncor to Texas Transmission Investment LLC pursuant to the Contribution and Subscription Agreement, dated as of August 12, 2008, between Oncor and Texas Transmission Investment LLC (the “Minority Sale”), as determined in good faith by the Managing Member of the Company (the “Managing Member”).

          (b) Subject to certain terms and conditions, including those hereinafter set forth and as set forth in the Stock Appreciation Rights Plan, which may include the Management Stockholder’s acquisition of the Purchased Units, Oncor will grant Stock

Appreciation Rights, based on a determination by the Chief Executive Officer of Oncor and the Organization and Compensation Committee of the board of directors of Oncor, to the Management Stockholder, at an initial exercise price equal to the Base Price, to participate in the economic equivalent of the appreciation of the Oncor Units as set forth in the Stock Appreciation Rights Plan.

          (c) The Company shall have no obligation to sell any Purchased Units to any person who (i) is a resident or citizen of a state or other jurisdiction in which the sale of the Purchased Units to him or her would constitute a violation of the securities or “blue sky” laws of such jurisdiction or (ii) is not an officer, director or employee of the Company or Oncor (or any Affiliate of Oncor (the material assets of which consist only of its direct or indirect interest in Oncor, or the assets of Oncor) used for the purposes of effecting a Public Offering of the vehicle holding the assets of Oncor (an “IPO Vehicle”)) (the “Management Stockholder Employer”).

          2. Management Stockholder’s Representations, Warranties and Agreements.

          (a) The Management Stockholder agrees and acknowledges that he or she will not, directly or indirectly, offer, transfer, sell, assign, pledge, hypothecate or otherwise dispose of (any of the foregoing acts being referred to herein as a “Transfer”) any (x) Purchased Units, or (y) equity interests in Oncor (or any IPO Vehicle) issued in respect of Stock Appreciation Rights or distributed to the Management Stockholder by the Company (“Oncor Units”, together with all equity interests in the Company, equity interests in Oncor or equity interests in any IPO Vehicle otherwise acquired and/or held by the Management Stockholder Entities, as of or after the date hereof, and any successor security of any of the foregoing, “Units”), except as provided in this Section 2(a) and Section 3 hereof. If the Management Stockholder is an Affiliate of any Management Stockholder Employer, the Management Stockholder also agrees and acknowledges that he or she will not Transfer any such Units unless:

     (i) the Transfer is pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations in effect thereunder (the “Act”), and in compliance with applicable provisions of state securities or “blue sky” laws; or

     (ii) (A) counsel for the Management Stockholder (which counsel shall be reasonably acceptable to the Company, Oncor or the IPO Vehicle, as applicable) shall have furnished the Company, Oncor or the IPO Vehicle, as applicable, with an opinion or other advice, reasonably satisfactory in form and substance to the Company, Oncor or the IPO Vehicle, as applicable, that no such registration is required because of the availability of an exemption from registration under the Act and (B) if the Management Stockholder is a citizen or resident of any country other than the United States, or the Management Stockholder desires to effect any Transfer in any such country, counsel for the Management Stockholder (which counsel shall be reasonably satisfactory to the Company, Oncor or the IPO Vehicle, as applicable) shall have furnished the Company, Oncor or the IPO Vehicle, as applicable, with an opinion or other advice reasonably satisfactory in form and substance to the Company, Oncor or the IPO Vehicle, as applicable, to the effect that such Transfer will comply with the securities laws of such jurisdiction.

Notwithstanding the foregoing, the Company and Oncor acknowledge and agree that any of the following Transfers of Units are deemed to be in compliance with the Act and this Agreement (including without limitation any restrictions or prohibitions herein), and no opinion of counsel is required in connection therewith: (1) a Transfer made pursuant to Sections 3, 4, 5, 6 or 9 hereof, (2) a Transfer (x) upon the death or Disability of the Management Stockholder to the Management Stockholder’s Estate or (y) to the executors, administrators, testamentary trustees, legatees, immediate family members or beneficiaries of a person who has become a holder of Units in accordance with the terms of this Agreement; provided that it is expressly understood that any such transferee shall be bound by the provisions of this Agreement and if requested such transferee shall agree in writing to be bound by the terms and conditions hereof as a “Management Stockholder” with respect to the representations and warranties and other obligations of this Agreement, (3) a Transfer made in compliance with the federal securities laws to a Management Stockholder’s Trust; provided that such Transfer is made expressly subject to this Agreement and that the transferee agrees in writing to be bound by the terms and conditions hereof as a “Management Stockholder” with respect to the representations and warranties and other obligations of this Agreement; and provided further that it is expressly understood and agreed that if such Management Stockholder’s Trust at any point includes any person or entity other than the Management Stockholder, his spouse (or ex-spouse) or his lineal descendants (including adopted children) such that it fails to meet the definition thereof as set forth in Section 7(b) hereof, such Transfer shall no longer be deemed in compliance with this Agreement and shall be subject to Section 3(c) below and (4) a Transfer made by the Management Stockholder, with the Managing Member’s or the board of directors of Oncor’s, or the IPO Vehicle’s, as applicable, approval, to the Company or Oncor, as applicable, or their designee.

          (b) The certificate (or certificates) representing the Units, if any, shall bear the following legend:

“THE UNITS REPRESENTED BY THIS CERTIFICATE MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS SUCH TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION COMPLIES WITH THE PROVISIONS OF THE MANAGEMENT STOCKHOLDER’S AGREEMENT AMONG ONCOR MANAGEMENT INVESTMENT LLC (THE “COMPANY”), ONCOR ELECTRIC DELIVERY COMPANY LLC (“ONCOR”) AND THE MANAGEMENT STOCKHOLDER NAMED ON THE FACE HEREOF OR THE SALE PARTICIPATION AGREEMENT AMONG SUCH MANAGEMENT STOCKHOLDER, ONCOR ELECTRIC DELIVERY HOLDINGS COMPANY LLC, IN EACH CASE EFFECTIVE AS OF NOVEMBER 5, 2008 (COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF ONCOR) AND ALL APPLICABLE FEDERAL AND STATE SECURITIES LAWS.”

          (c) The Management Stockholder acknowledges that he or she has been advised that (i) the Units are characterized as “restricted securities” under the Act inasmuch as they are being acquired from the Company, Oncor or the IPO Vehicle in a transaction not involving a Public Offering and that under the Act (including applicable regulations) the Units may be resold without registration under the Act only in certain limited circumstances,

(ii) a restrictive legend in the form heretofore set forth shall be placed on the certificates (if any) representing the Units and (iii) a notation shall be made in the appropriate records of the Company, Oncor or the IPO Vehicle, as applicable, indicating that the Units are subject to restrictions on Transfer and appropriate stop transfer restrictions will be issued to the Company’s, Oncor’s or the IPO Vehicle’s, as applicable, transfer agent with respect to the Units.

          (d) If any Units are to be disposed of in accordance with Rule 144 under the Act or otherwise, the Management Stockholder shall promptly notify the Company, Oncor or the IPO Vehicle, as applicable, of such intended disposition and shall deliver to the Company, Oncor or the IPO Vehicle, as applicable, at or prior to the time of such disposition such documentation as the Company, Oncor or the IPO Vehicle, as applicable, may reasonably request in connection with such sale and, in the case of a disposition pursuant to Rule 144, shall deliver to the Company, Oncor or the IPO Vehicle, as applicable, an executed copy of any notice on Form 144 required to be filed with the SEC.

          (e) The Management Stockholder represents and warrants that (i) with respect to the Units and Stock Appreciation Rights, the Management Stockholder has received and reviewed the available information relating to such Units and Stock Appreciation Rights, including a Preliminary Confidential Private Placement Memorandum and any supplements thereto, including having received and reviewed the documents related thereto, certain of which documents set forth the rights, preferences and restrictions relating to the Units and the Stock Appreciation Rights and (ii) the Management Stockholder has been given the opportunity to obtain any additional information or documents, and to ask questions and receive answers about such information and documents, regarding the Company, Oncor and the business and prospects of the Company and Oncor which the Management Stockholder deems necessary to evaluate the merits and risks related to the Management Stockholder’s investment in the Units and any Stock Appreciation Rights and to verify the information contained in the information received as indicated in this Section 2(e), and the Management Stockholder has relied solely on such information.

          (f) The Management Stockholder further represents and warrants that (i) the Management Stockholder’s financial condition is such that the Management Stockholder can afford to bear the economic risk of holding his or her Units for an indefinite period of time and has adequate means for providing for the Management Stockholder’s current needs and personal contingencies, (ii) the Management Stockholder can afford to suffer a complete loss of his or her investment in the Units, (iii) the Management Stockholder understands and has taken cognizance of all risk factors related to the purchase of the Units, (iv) the Management Stockholder’s knowledge and experience in financial and business matters are such that the Management Stockholder is capable of evaluating the merits and risks of the Management Stockholder’s purchase of the Units as contemplated by this Agreement, (v) with respect to the Purchased Units, such Purchased Units are being acquired by the Management Stockholder for his or her own account, not as nominee or agent, and not with a view to the resale or distribution of any part thereof in violation of the Act, and the Management Stockholder has no present intention of selling or otherwise distributing the Purchased Units in violation of the Act, and (vi) the Management Stockholder is (a) if the applicable box on the signature page hereto has been checked, an “accredited investor”¹

within the meaning of Rule 501(a) under the Securities Act that is willing and able to conduct an independent investigation of the risks of investing in the Company, or, if not an accredited investor, and (b) if such box has not been checked, an employee, director or officer of a Management Stockholder Employer.

          3. Transferability of Units.

          (a) The Management Stockholder agrees that he or she will not Transfer any Units at any time during the period commencing on the date hereof and ending on the later of (x) October 10, 2012 and (y) for any Subject Stock (as defined below in the definition of “Qualified Public Offering”), the consummation of a Qualified Public Offering with respect to such Subject Stock; provided, however, that during such period, the Management Stockholder may Transfer Units pursuant to one of the following exceptions: (i) Transfers permitted by Sections 4, 5 or 6; (ii) Transfers permitted by clauses (2) and (3) of Section 2(a); (iii) a sale of Units pursuant to Section 9; (iv) Transfers permitted pursuant to the Sale Participation Agreement; (v) Transfers permitted by the Managing Member, board of directors of Oncor or the IPO Vehicle, as applicable, or (vi) Transfers to the Company, Oncor or the IPO Vehicle, as applicable, or their designee (any such exception, a “Permitted Transfer”).

          (b) No Transfer of any such Units in violation hereof or in violation of applicable law shall be made or recorded on the books of the Company, Oncor or the IPO Vehicle and any such Transfer shall be void ab initio and of no effect.

          (c) No Transfer of any Units shall be permitted or effected if such Transfer would cause the Company, Oncor or the IPO Vehicle to be required to register the Management Units or the Oncor Units pursuant to Section 12(g)(1) of the Exchange Act.

          (d) Notwithstanding anything to the contrary herein, the Company, Oncor or the IPO Vehicle, as the case may be, may, at any time and from time to time, waive the restrictions on Transfers contained in Section 3(a), whether such waiver is made prior to or after the transferee has effected or committed to effect the Transfer, or has notified the Company, Oncor or the IPO Vehicle, as the case may be, of such Transfer or commitment to Transfer. Any Transfers made pursuant to such waiver or which are later made subject to such a waiver shall, as of the date of the waiver and at all times thereafter, not be deemed to violate any applicable restrictions on Transfers contained in this Agreement.

          4. Rights on Certain Liquidity Events.

          (a) In the event that at any time on or after the date hereof Parent or any member of the Sponsor Group proposes to sell directly for cash or any other consideration any shares of EFH Common Stock owned by Parent or 50% or more of the outstanding

	•		any director or executive officer of Oncor;
	•		any natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of purchase exceeds $1 million; or
	•		any natural person who for the two most recent years had an individual income in excess of $200,000, or joint income with that person’s spouse in excess of $300,000 and has a reasonable expectation of reaching that same level of income in the current year.

limited partnership units of Parent in any transaction (other than an offering pursuant to a registration statement on Form S-4 or Form S-8 (or similar forms) or a sale, directly or indirectly, to an Affiliate of Parent or any member of the Sponsor Group), in which management members of EFH Corp. (“EFH Management”) are permitted to sell shares of EFH Common Stock pursuant to any “tag rights” or “piggy-back rights” under a sale participation agreement, registration rights agreement or similar agreement with EFH Corp. or Parent (“EFH Management Sale”), then, unless Parent or a member of the Sponsor Group is entitled to and does exercise the drag-along rights pursuant to an EFH Drag Transaction (as defined below), at the option of the Management Stockholder, the Management Stockholder shall have the right, subject to any terms, conditions, limitations or adjustments imposed on any EFH Management Sale and on completion of such EFH Management Sale, to offer for redemption Management Units to the Company, Oncor Units to Oncor or successor common equity of the IPO Vehicle (“IPO Stock”) to the IPO Vehicle, as applicable, and the Company, Oncor or the IPO Vehicle, as applicable, shall be required to repurchase (subject to any legal or contractual limitations on liquidity at the Company, Oncor or the IPO Vehicle), on one occasion, a number of Management Units, Oncor Units or shares of IPO Stock, as applicable, held by the Management Stockholder equal to (x) the total number of Management Units, Oncor Units or IPO Stock, as applicable, held by the Management Stockholder multiplied by (y) the EFH Sale Percentage, at a per unit price equal to the Fair Market Value as determined as of the date that the price to be received by Parent or member of the Sponsor Group, as applicable, is determined. The “EFH Sale Percentage” shall mean the fraction, expressed as a percentage, determined by (i) with respect to sales of EFH Common Stock, dividing the number of shares of EFH Common Stock to be purchased from Parent pursuant to the applicable transaction that would cause the provisions contained in Sections 4(a) or 4(b) hereof to take effect, by the total number of shares of EFH Common Stock owned by Parent, or (ii) with respect to sales of limited partnership units of Parent, dividing the number of limited partnership units of Parent to be purchased from members of the Sponsor Group pursuant to the applicable transaction that would cause the provisions contained in Sections 4(a) or 4(b) hereof to take effect, by the total number of limited partnership units of Parent owned by such selling members of the Sponsor Group.

          (b) If Parent or a member of the Sponsor Group proposes to sell, directly or indirectly (without duplication) (whether by means of a merger, consolidation, reorganization or recapitalization, sale, transfer or otherwise), a number of shares of EFH Common Stock or limited partnership units of Parent equal to 50% or more of the outstanding EFH Common Stock or limited partnership units of Parent, as applicable (such Person, the “EFH Drag-Along Purchaser”), then, if requested by Parent or a member of the Sponsor Group, each Management Stockholder shall be required to offer for redemption a number of Units to the Company or Oncor or IPO Stock to the IPO Vehicle, as applicable, equal to the aggregate number of Units held by the Management Stockholder, multiplied by the EFH Sale Percentage (such transaction, an “EFH Drag Transaction”), subject to any terms, conditions, limitations or adjustments imposed on any EFH Management Sales, at a per unit price equal to the Fair Market Value as determined as of the date that the price to be received by Parent or member of the Sponsor Group, as applicable, is determined.

          (c) In the event of any EFH Management Sale or EFH Drag Transaction under this Section 4, the Company, Oncor or the IPO Vehicle, as applicable, will provide the Management Stockholder with notice substantially similar to any notice provided to EFH

Management upon receiving notice of such transactions from EFH Corp or a member of the Sponsor Group.

          (d) In the event that at any time prior to a Public Offering of Oncor Units or IPO Stock, a Related Entity proposes to sell directly for cash or any other consideration any Oncor Units owned by a Related Entity in any transaction (other than an offering pursuant to a registration statement on Form S-4 or Form S-8 (or similar forms) or in connection with the initial Public Offering of Oncor Units or IPO Stock pursuant to a registration statement under the Act which has been declared effective by the SEC or a sale, directly or indirectly, to an Affiliate of such Related Entity), then, unless such Related Entity is entitled to and does exercise the drag-along rights pursuant to an Oncor Drag Transaction (as defined below), at the option of the Management Stockholder, the Management Stockholder shall have the right, subject to any terms, conditions, limitations or adjustments imposed on the sale by such Related Entity and on completion of such sale, to offer for redemption Management Units to the Company, and the Company shall be required to repurchase (subject to any legal or contractual limitations on liquidity at the Company), on one occasion, a number of Management Units held by the Management Stockholder Entity equal to (x) the total number of Management Units held by the Management Stockholder Entity multiplied by (y) the Oncor Sale Percentage, at a per unit price equal to the Fair Market Value as determined as of the date that the price to be received by such Related Entity is determined. The “Oncor Sale Percentage” shall mean the fraction, expressed as a percentage, determined by dividing the number of Oncor Units to be purchased from the relevant Related Entity pursuant to the applicable transaction that would cause the provisions contained in Sections 4(d) or 4(e) hereof to take effect, by the total number of Oncor Units owned by such Related Entity.

          (e) If a Related Entity proposes to sell, directly or indirectly (whether by means of a merger, consolidation, reorganization or recapitalization, sale, transfer or otherwise), a number of Oncor Units equal to 50% or more of the outstanding Oncor Units (such Person, the “Oncor Drag-Along Purchaser”), then, if requested by such Related Entity, each Management Stockholder shall be required to offer for redemption to the Company, and the Company will be required to repurchase (subject to any legal or contractual limitations on liquidity at the Company), a number of Management Units equal to the aggregate number of Management Units held by the Management Stockholder, multiplied by the Oncor Sale Percentage (such transaction, an “Oncor Drag Transaction”), subject to any terms, conditions, limitations or adjustments imposed on the sale by Oncor Holdings, at a per unit price equal to the Fair Market Value as determined as of the date that the price to be received by such Related Entity is determined.

          (f) In the event of any transaction that would cause the provisions contained in Sections 4(d) and 4(e) hereof to take effect, the relevant Related Entity will provide the Management Stockholder with notice of such proposed sale specifying the principal terms and conditions of such proposed sale including (A) the number of Oncor Units proposed to be included in such proposed sale, (B) the percentage of the outstanding Oncor Units at the time the notice is given that is represented by the number of Oncor Units proposed to be included in such proposed sale, (C) the price per Oncor Unit subject to such proposed sale, including a description of any pricing formulae and of any non-cash consideration, (D) the Oncor Sale Percentage (as defined above) of the relevant Related

Entity and (E) the name and address of the Person to whom the Oncor Units is proposed to be sold.

          (g) If, within 10 Business Days after the delivery of any notice under Section 4(c) or (f), the Company or Oncor, as applicable, receives from a Management Stockholder a written request (a “Request”) to Transfer Units pursuant to the terms of Section 4(a) or (d), as applicable (which Request shall be irrevocable except (a) as provided for by any terms, conditions, limitations or adjustments imposed on any EFH Management Sales or on sale of Oncor Units by a Related Entity or (b) if otherwise mutually agreed to in writing by the Management Stockholder Entity and the transferee of the Units) then such Management Stockholder shall be considered to have validly exercised his rights as provided for under Section 4(a) or (d), as applicable. If a Request is not received by the Company or Oncor, as applicable, within the time period stated in the preceding sentence, the Management Stockholder’s rights under Section 4(a) and (d) shall have been waived.

          (h) Leveraged Recapitalization Transactions. In the event that at any time after the date hereof EFH Corp. consummates a leveraged recapitalization transaction pursuant to which members of EFH Management who are holders of shares of EFH Common Stock are entitled to receive an extraordinary special dividend from the proceeds of such transaction, then the Management Shareholders shall receive from Oncor or the IPO Vehicle, as applicable, a liquidity opportunity, comparable adjustment or other payment in a manner and in an amount which is similar to that received by members of EFH Management who are holders of shares of EFH Common Stock, as the board of Oncor determines is equitable and appropriate.

          (i) Use of Note to Satisfy Payment. Notwithstanding anything in this Agreement to the contrary, if an Event (as defined in Section 5(c)) exists, or may exist as a result of a purchase by the Company, Oncor or the IPO Vehicle pursuant to this Section 4, and the Company, Oncor or the IPO Vehicle elects or is required to purchase Units pursuant to this Section 4, the Company, Oncor or the IPO Vehicle, as applicable, may elect to pay the consideration for any such purchase pursuant to (i) a cash payment for any amounts payable pursuant to this Section 4 or (ii) a note having the same terms as that provided in Section 5(c) below with a principal amount equal to the amount payable. Notwithstanding the foregoing, if an Event exists and is continuing for ninety (90) days from the date of delivery of the notice under Section 4(c) or (f), as applicable, the Management Stockholder Entities shall be permitted by written notice to rescind any Request with respect to that portion of the Units repurchased by the Company, Oncor or the IPO Vehicle, as applicable, from the Management Stockholder Entities pursuant to this Section 4 with the note described in the foregoing sentence, to the extent such note remains unpaid; provided that, upon such rescission, such repurchase shall be immediately rescinded and such note shall be immediately canceled without any action on the part of the Company, Oncor, the IPO Vehicle or the Management Stockholder Entities and, notwithstanding anything herein or in such note to the contrary, the Company, Oncor and the IPO Vehicle shall have no obligation to pay any amounts of principal or interest thereunder.

          (j) Timing of Payment. Notwithstanding anything to the contrary contained in this Section 4, payment of consideration for any Transfer of Units by the Company shall in no event be due earlier than on or about the second business day after the date of payment of the next regular quarterly dividend paid by Oncor following the date of Transfer.

          (k) Termination. Notwithstanding anything in this Agreement to the contrary, this Section 4 shall terminate and be of no further force or effect upon the earlier of (i) a Change in Control, or (ii) the later of (x) October 10, 2012 or (y) for any Subject Stock, the consummation of a Qualified Public Offering with respect to that Subject Stock, except for any payment obligation of the Company, Oncor or the IPO Vehicle or Transfer obligation of the Management Stockholder Entities which has arisen prior to such termination date.

5.

The Management Stockholder’s Right to Resell Units and Stock Appreciation Rights to the Company or Oncor, as Applicable.

          (a) Except as otherwise provided herein, if the Management Stockholder’s employment with the Management Stockholder Employer terminates as a result of the death or Disability of the Management Stockholder, then the applicable Management Stockholder Entity shall, during the later of the following: (x) the 365-day period following the date of such termination for death or Disability or (y) if the Company, Oncor or the IPO Vehicle has declared that an Event (as defined below) has occurred, the 30-day period following the date on which the Management Stockholder Entity receives notice that the Event which was declared by the Company, Oncor or the IPO Vehicle, as applicable, while the Management Stockholder Entity held the Units, no longer exists; provided, however, the Management Stockholder Entity shall not be entitled to exercise the Management Stockholder’s rights pursuant to this Section 5 unless the Management Stockholder Entity has held the Units to be resold pursuant to this Section 5 for at least six (6) months (including as a result of net settlement as specified in Section 5(a)(ii)) (the “Redemption Period”), have the right to:

     (i) With respect to Units, offer for redemption to the Company, Oncor or the IPO Vehicle, as applicable, and the Company, Oncor or the IPO Vehicle, as applicable, shall be required to repurchase, on one occasion, all of the Units then held by the applicable Management Stockholder Entities at a per unit price equal to the Fair Market Value on the Repurchase Calculation Date;

     (ii) With respect to any outstanding vested Stock Appreciation Rights, upon the occurrence of the applicable event identified in this Section 5 giving rise to the Management Stockholder’s rights hereunder, Oncor or the IPO Vehicle, as applicable, shall deem the Management Stockholder Entity to have exercised the outstanding vested Stock Appreciation Rights, in accordance with the terms of the relevant Stock Appreciation Rights Agreement, and be entitled to receive from Oncor or the IPO Vehicle, as applicable, on one occasion, in exchange for all of the outstanding vested Stock Appreciation Rights then held by the applicable Management Stockholder Entity, if any, cash equal to the product of (A) the excess, if any, of the Fair Market Value on the Repurchase Calculation Date over the Base Price and (B) the number of Stock Appreciation Rights then credited to such Management Stockholders Account. In the event the foregoing amount is zero or a negative number, all outstanding vested Stock Appreciation Rights shall be automatically terminated without any payment in respect thereof; and

          (iii) With respect to any outstanding unvested Stock Appreciation Rights, all outstanding unvested Stock Appreciation Rights shall be terminated and cancelled without any payment in respect thereof.

          (b) Notice. In the event the applicable Management Stockholder Entities intend to exercise their rights pursuant to Section 5(a), such Management Stockholder

Entities shall send written notice to the Company, Oncor or the IPO Vehicle, as applicable, at any time during the Redemption Period, of their intention to offer for redemption Units (including redemption of Stock Appreciation Rights for cash) in exchange for the payments referred to in Section 5(a)(i) and (a)(ii) and shall indicate the number of Stock Appreciation Rights and Units to be sold (the “Redemption Notice”). The completion of the purchases shall take place at the principal office of Oncor no later than, subject to Section 5(e) below which provides for the payment shortly following payment of quarterly dividends by Oncor, the twentieth Business Day (such date to be determined by the Company, Oncor or the IPO Vehicle, as applicable) after the giving of the Redemption Notice. The applicable Redemption Price shall be paid by delivery to the applicable Management Stockholder Entities, at the option of the Company, Oncor or the IPO Vehicle, as applicable, of a certified bank check or checks in the appropriate amount payable to the order of each of the applicable Management Stockholder Entities (or by wire transfer of immediately available funds, if the Management Stockholder Entities provide to Oncor wire transfer instructions) against delivery of certificates or other instruments representing the Units so purchased.

          (c) Use of Note to Satisfy Call Payment. Notwithstanding anything in this Section 5 to the contrary, if there exists and is continuing a default or an event of default on the part of the Company, Oncor, the IPO Vehicle or any of their respective Subsidiaries under any loan, guarantee or other agreement under which the Company, Oncor, the IPO Vehicle or any of their respective Subsidiaries has borrowed money or if the repurchase or redemption referred to in Section 5(a) (or Section 4 or Section 6 hereof, as the case may be) would result in a default or an event of default on the part of the Company, Oncor, the IPO Vehicle or any of their respective Subsidiaries under any such agreement or if a repurchase or redemption would reasonably be expected to be prohibited by the Delaware Limited Liability Company Act (“DLLCA”), Public Utility Commission of Texas or any federal or state securities laws or regulations (or if the Company, Oncor, the IPO Vehicle or any of their respective Subsidiaries reorganizes in another state, the business corporation law, limited liability company law or other law of such state) (each such occurrence being an “Event”), the Company, Oncor and/or the IPO Vehicle, as applicable, shall not be obligated to repurchase or redeem any of the Units or the Stock Appreciation Rights from the applicable Management Stockholder Entities to the extent it would cause any such default, or would be so prohibited by the Event, for cash but instead, with respect to such portion with respect to which cash settlement is prohibited, may satisfy its obligations with respect to the Management Stockholder Entities’ exercise of their rights under Section 5(a) by delivering to the applicable Management Stockholder Entity a note with a principal amount equal to the amount payable under this Section 5 that was not paid in cash, having terms acceptable to the Company, Oncor, the IPO Vehicle or any of their respective Subsidiaries, as applicable, lenders and permitted under the Company, Oncor, the IPO Vehicle or any of their respective Subsidiaries, as applicable, debt instruments but which in any event (i) shall be mandatorily repayable promptly to the extent that an Event no longer prohibits the payment of cash to the applicable Management Stockholder Entity pursuant to this Agreement; and (ii) shall bear interest at a rate equal to the effective rate of interest in respect of Oncor’s U.S. dollar-denominated subordinated public debt securities.

          (d) Rescission. Notwithstanding the foregoing and subject to Section 5(c), if an Event exists and is continuing for ninety (90) days after the date of the Redemption Notice, the Management Stockholder Entities, shall be permitted by written notice to rescind any Redemption Notice with respect to that portion of the Units repurchased by the Company, Oncor or the IPO Vehicle, as applicable, from the Management Stockholder

Entities pursuant to this Section 5 with the note described above, to the extent such note remains unpaid, and such repurchase or redemption shall be rescinded; provided that, upon such rescission, such note shall be immediately canceled without any action on the part of the Company, Oncor, the IPO Vehicle or the Management Stockholder Entities, and notwithstanding anything herein or in such note to the contrary, the Company, Oncor, the IPO Vehicle and their Affiliates shall have no obligation to pay any amounts of principal or interest thereunder.

          (e) Timing of Payment. Notwithstanding anything to the contrary contained in this Section 5, payment on any Transfer of Units by the Company shall in no event be due earlier than on or about the second business day after the date of payment of the next regular quarterly dividend paid by Oncor following the date of Transfer, as applicable.

          (f) Termination. Notwithstanding anything in this Agreement to the contrary, this Section 5 shall terminate and be of no further force or effect upon the earlier of (i) a Change in Control, or (ii) the later of (x) October 10, 2012 or (y) for a Subject Stock, the consummation of a Qualified Public Offering with respect to that Subject Stock, except for any payment obligation of the Company, Oncor or the IPO Vehicle or Transfer obligation of the Management Stockholder Entities which has arisen prior to such termination date.

6.

The Company’s and Oncor’s Option to Purchase Units and Redeem Stock Appreciation Rights of the Management Stockholder Upon Certain Terminations of Employment.

          (a) Termination by the Management Stockholder without Good Reason. If the Management Stockholder’s active employment with the Management Stockholder Employer is terminated by the Management Stockholder without Good Reason, other than on account of death, Disability or Retirement (such event, a “Section 6(a) Call Event”), then:

     (i) With respect to any Purchased Units, the Company, Oncor or the IPO Vehicle, as the case may be, may purchase, on one occasion, all or any portion of such Management Units, then held by the applicable Management Stockholder Entities at a per unit purchase price equal to the Base Price, but only if such termination occurs prior to October 10, 2012;

     (ii) With respect to any Oncor Units or IPO Stock, as applicable, issued in respect of vested Stock Appreciation Rights, Oncor or the IPO Vehicle may purchase, on one occasion, all or any portion of the Oncor Units or shares of such IPO Stock, as applicable, then held by the applicable Management Stockholder Entities at a per unit purchase price equal to (x) if such termination occurs prior to October 10, 2012, the per unit Fair Market Value of Oncor Units or IPO Stock, as applicable, less 20% of the amount, if any, by which such per unit Fair Market Value exceeds the Base Price of the underlying Stock Appreciation Rights in respect of which such units or shares were issued, or (y) if such termination occurs on or after October 10, 2012, the per unit Fair Market Value of Oncor Units or IPO Stock, as applicable, on the Repurchase Calculation Date;

     (iii) With respect to any vested Stock Appreciation Rights, Oncor may

redeem, on one occasion, all or any portion of such Stock Appreciation Rights then held by the applicable Management Stockholder Entities at a per unit purchase price equal to (x) if such termination occurs prior to October 10, 2012 the excess, if any, of the Fair Market Value on the Repurchase Calculation Date over the Base Price less 20 percent of the excess, if any, by which such Fair Market Value exceeds the Base Price, or (y) if such termination occurs on or after October 10, 2012, the excess, if any, of the Fair Market Value on the Repurchase Calculation Date over the Base Price of the underlying Stock Appreciation Rights. In the event the foregoing amount is zero or a negative number, all outstanding vested Stock Appreciation Rights shall be automatically terminated without any payment in respect thereof;

     (iv) With respect to any cash payment received in respect of vested and exercised Stock Appreciation Rights, the applicable Management Stockholder Entity shall be required to pay to Oncor or the IPO Vehicle, as applicable, 20% of the excess, if any, by which such cash payment exceeds the Base Price of the underlying Stock Appreciation Rights in respect of which such cash payment was made, if such termination occurs prior to October 10, 2012 (for the avoidance of doubt, this paragraph (iv) shall in no way diminish rights granted under paragraph (iii) above); and

     (v) With respect to any outstanding unvested Stock Appreciation Rights, all outstanding unvested Stock Appreciation Rights will be automatically terminated without any payment in respect thereof upon the occurrence of the Section 6(a) Call Event.

          For the avoidance of any doubt, the termination of the Management Stockholder’s active employment with the Management Stockholder Employer by the Management Stockholder without Good Reason following October 10, 2012 shall not constitute a Section 6(a) Call Event with respect to the Purchased Units.

          (b) Termination for Cause and other Call Events. If at any time (i) the Management Stockholder’s active employment with the Management Stockholder Employer is terminated by the Management Stockholder Employer for Cause or (ii) within twelve (12) months following any termination of the Management Stockholder’s employment with the Management Stockholder Employer, the Management Stockholder engages in a Competing Business (such event under item (ii) above, a “Section 6(b)(ii) Call Event” and each event described above under items (i) and (ii), a “Section 6(b) Call Event”), then:

     (i) With respect to Purchased Units held by the Management Stockholder, the Company, Oncor or the IPO Vehicle, as the case may be, may purchase, on one occasion, all or any portion of such Management Units then held by the applicable Management Stockholder Entities at a per unit purchase price equal to the lesser of (x) Base Price (or other applicable price paid by such Management Stockholder Entities for the Management Units) and (y) Fair Market Value of the Management Units;

     (ii) With respect to any Oncor Units or IPO Stock or cash payment received in respect of vested and exercised Stock Appreciation Rights, the applicable Management Stockholder Entity shall be required to return the Oncor Units or IPO

Stock to, or pay any amounts actually paid to him or her or otherwise received in respect of any exercise or disposition of any Stock Appreciation Rights, as applicable, to Oncor or the IPO Vehicle;

     (iii) With respect to any outstanding Stock Appreciation Rights (whether vested or unvested) all outstanding Stock Appreciation Rights shall be automatically terminated or forfeited, as applicable, without any payment in respect thereof upon the occurrence of the Section 6(b) Call Event; and

     (iv) Notwithstanding the foregoing, to the extent the Management Stockholder engages in a Section 6(b)(ii) Call Event after the Management Stockholder has exercised his or her outstanding Stock Appreciation Rights or received cash in respect of any repurchase or disposition of any Management Units, Oncor Units or IPO Stock, Section 22(c) shall apply.

          (c) Call Notice. The Company, Oncor or the IPO Vehicle, as applicable, shall have a period (the “Call Period”) of one hundred eighty (180) days following the later to occur of (A) the date of any Call Event and (B) the date on which the Management Stockholder Entity has held the Units or Stock Appreciation Rights most recently acquired to be sold or redeemed pursuant to this Section 6 for at least six (6) months, in which to give notice in writing to the Management Stockholder of its election to exercise its rights and obligations pursuant to this Section 6 (“Repurchase Notice”). The completion of the purchases pursuant to the foregoing shall take place at the principal office of the Company, Oncor or the IPO Vehicle, as applicable, no later than, subject to Section 6(e) below which provides for the payment of quarterly dividends by Oncor or the IPO Vehicle, the fifteenth Business Day after the giving of the Repurchase Notice. The applicable Repurchase Price shall be paid by delivery to the applicable Management Stockholder Entities of a certified bank check or checks in the appropriate amount payable to the order of each of the applicable Management Stockholder Entities (or by wire transfer of immediately available funds, if the Management Stockholder Entities provide to the Company, Oncor or the IPO Vehicle, as applicable wire transfer instructions) against delivery of certificates or other instruments representing the Units so purchased. For purposes of this Section 6, any determination of Fair Market Value shall be made as of the Repurchase Calculation Date.

          (d) Use of Note to Satisfy Call Payment. Notwithstanding any other provision of this Section 6 to the contrary, if there exists and is continuing any Event, the Company, Oncor or the IPO Vehicle will, to the extent it has exercised its rights to purchase Units or redeem any Stock Appreciation Rights pursuant to this Section 6, in order to complete the purchase of any Units or redeem any Stock Appreciation Rights pursuant to this Section 6, deliver to the applicable Management Stockholder Entities (i) a cash payment for any amounts payable pursuant to this Section 6 that would not cause an Event and (ii) a note having the same terms as that provided in Section 5(c) above with a principal amount equal to the amount payable but not paid in cash pursuant to this Section 6 due to the Event. Notwithstanding the foregoing, if an Event exists and is continuing for ninety (90) days from the date of the Section 6(b) Call Event, the Management Stockholder Entities shall be permitted by written notice to cause the Company, Oncor or the IPO Vehicle, as applicable, to rescind any Repurchase Notice with respect to that portion of the Units repurchased or Stock Appreciation Rights redeemed by the Company, Oncor or the IPO Vehicle from the Management Stockholder Entities pursuant to this Section 6 with the note described in the

foregoing sentence, to the extent such note remains unpaid; provided that, upon such rescission, such repurchase or redemption shall be immediately rescinded and such note shall be immediately canceled without any action on the part of the Company, Oncor, the IPO Vehicle or the Management Stockholder Entities and, notwithstanding anything herein or in such note to the contrary, the Company, Oncor and the IPO Vehicle shall have no obligation to pay any amounts of principal or interest thereunder.

          (e) Timing of Payment. Notwithstanding anything to the contrary contained in this Section 6, payment on any Transfer of Units by the Company shall in no event be due earlier than on or about the second business day after the date of payment of the next regular quarterly dividend paid by Oncor following the date of Transfer.

          (f) Termination. Notwithstanding anything in this Agreement to the contrary, this Section 6 shall terminate and be of no further force or effect upon the earlier of (i) a Change in Control, or (ii) the later of (x) October 10, 2012 or (y) for a Subject Stock, the consummation of a Qualified Public Offering with respect to that Subject Stock, except for any payment obligation of the Company, Oncor or the IPO Vehicle or Transfer obligation of the Management Stockholder Entities which has arisen prior to such termination date.

          7. Adjustment of Repurchase Price; Definitions.

          (a) Adjustment of Repurchase Price. In determining the applicable repurchase price of the Units and Stock Appreciation Rights, as provided for in Sections 4, 5 and 6, above, appropriate adjustments shall be made for any stock or unit dividends, splits, combinations, recapitalizations or any other adjustment in the number of outstanding Units in order to maintain, as nearly as practicable, the intended operation of the provisions of Sections 4, 5 and 6.

          (b) Definitions. All capitalized terms used in this Agreement and not defined herein shall have the meaning ascribed to such terms in the Stock Appreciation Rights Plan. Terms used herein and as listed below shall be defined as follows:

     “Account” shall mean a book account of Oncor where Stock Appreciation Rights will be credited.

     “Act” shall have the meaning set forth in Section 2(a)(i) hereof.

     “Affiliate” means with respect to any Person, any entity directly or indirectly controlling, controlled by or under common control with such Person; provided, however, for purposes of this Agreement, Texas Energy Future Co-Invest, LP shall not be deemed to be an Affiliate of the Sponsor Group or any member of the Sponsor Group.

     “Agreement” shall have the meaning set forth in the introductory paragraph.

     “Base Price” shall have the meaning set forth in Section 1(a) hereof.

     “Business Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law to be closed in the state of New York.

     “Call Events” shall mean, collectively, Section 6(a) Call Events and Section 6(b) Call Events.

     “Call Period” shall have the meaning set forth in Section 6(c) hereof.

     “Cash Purchased Units” shall have the meaning set forth in the first recital.

     “Cause” shall mean “Cause” as such term may be defined in any employment agreement or change-in-control agreement in effect at the time of termination of employment between the Management Stockholder and the Management Stockholder Employer, or, if there is no such employment or change-in-control agreement, “Cause” means, with respect to a Management Stockholder: (i) if, in carrying out his or her duties to the Management Stockholder Employer, Management Stockholder engages in conduct that constitutes (a) a breach of his or her fiduciary duty to the Management Stockholder Employer, its Subsidiaries or their shareholders (including, without limitation a breach or attempted breach of the restrictive covenants under this Agreement), (b) gross neglect or (c) gross misconduct resulting in material economic harm to the Management Stockholder Employer or its Subsidiaries, taken as a whole, or (ii) upon the indictment of the Management Stockholder, or the plea of guilty or nolo contendere by Management Stockholder to, a felony or a misdemeanor involving moral turpitude.

     “Change in Control” shall mean, in one or a series of related transactions, (i) the sale of all or substantially all of the consolidated assets or capital stock of EFH Corp., Oncor Holdings or Oncor to a person (or group of persons acting in concert) who is not an Affiliate of any member of the Sponsor Group; (ii) a merger, recapitalization or other sale by EFH Corp., any member of the Sponsor Group or their Affiliates, to a person (or group of persons acting in concert) of EFH Common Stock that results in more than 50% of the EFH Common Stock (or any resulting company after a merger) being held by a person (or group of persons acting in concert) that does not include any member of the Sponsor Group or any of their respective Affiliates; or (iii) a merger, recapitalization or other sale of EFH Common Stock by EFH Corp., any member of the Sponsor Group or their Affiliates, after which the Sponsor Group owns less than 20% of the EFH Common Stock, and has the ability to appoint less than a majority of the directors to the board of directors of EFH Corp. (or of any resulting company after a merger); and with respect to any of the events described in clauses (i) and (ii) above, such event results in any person (or group of persons acting in concert) gaining control of more seats on the board of directors of EFH Corp. than the Sponsor Group; provided however, that not withstanding the foregoing, (x) clause (i) above shall be deemed not to include any reference to EFH Corp., and clauses (ii) and (iii) shall not apply, in each case, for purposes of interpreting the termination or applicability of any puts, calls or release from transfer restrictions upon Transfers of Oncor Units or equity units of Oncor Holdings, (y) clause (i) above shall be deemed not to include any reference to Oncor Holdings for purposes of interpreting the termination or applicability of any puts, calls or release from transfer restrictions upon Transfers of Oncor Units and (z) clause (i) above shall be deemed not to include any reference to Oncor for the purposes of interpreting the termination or applicability of any puts, calls or release from transfer restrictions upon Transfer of equity units of Oncor Holdings.

     “Company” shall have the meaning set forth in the introductory paragraph.

     “Competing Business” shall mean any business that directly or indirectly competes, at the relevant determination date, with one or more of the businesses of EFH Corp., Oncor, an IPO Vehicle or their respective Subsidiaries in any geographic area where EFH Corp., Oncor, an IPO Vehicle or their respective Subsidiaries operates.

     “Confidential Information” shall mean all non-public information concerning trade secret, know-how, software, developments, inventions, processes, technology, designs, the financial data, strategic business plans or any proprietary or confidential information, documents or materials in any form or media, including any of the foregoing relating to research, operations, finances, current and proposed products and services, customers, advertising and marketing, and other non-public, proprietary, and confidential information of the Restricted Group, excluding any such non-public information that (i) is required by court or administrative order to be disclosed or (ii) becomes generally available to the public other than as a result of a disclosure or failure to safeguard in violation of Section 22.

     “Deferred Purchased Units” shall have the meaning set forth in the first recital.

     “Disability” shall mean “Disability” as such term is defined in any employment agreement between the Management Stockholder and any Management Stockholder Employer, or, if there is no such employment agreement, “Disability” as defined in the then current long-term disability plan of EFH.

     “DLLCA” shall have the meaning set forth in Section 5(c) hereof.

     “Drag Transaction” shall have the meaning ascribed to such term in the Sale Participation Agreement.

     “EFH Common Stock” means shares of the common stock of EFH Corp., no par value.

     “EFH Corp.” shall mean Energy Future Holding Corp., a Texas corporation.

     “EFH Drag-Along Purchaser” shall have the meaning set forth in Section 4(b) hereof.

     “EFH Drag Transaction” shall have the meaning set forth in Section 4(b) hereof.

     “EFH Management” shall have the meaning set forth in Section 4(a) hereof.

     “EFH Management Sale” shall have the meaning set forth in Section 4(a) hereof.

     “EFH Sale Percentage” shall have the meaning set forth in Section 4(a) hereof.

     “EFH Seller” shall have the meaning set forth in Section 9 hereof.

     “Event” shall have the meaning set forth in Section 5(c) hereof.

     “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended (or any successor section thereto).

     “Fair Market Value” means with respect to Management Units, the Fair Market Value of a corresponding number of Oncor Units (or IPO Stock) on the date of determination as calculated pursuant to the following provisions: (i) if there is a public market for Oncor Units (or IPO Stock) on such date, the average of the high and low closing bid prices of the Oncor Units (or IPO Stock), as applicable, on such stock exchange on which the units are principally trading on the date in question, or, if there were no sales on such date, on the closest preceding date on which there were sales of units or, (ii) if there is no public market for the Oncor Units (or IPO Stock), on a per unit basis, the Fair Market Value of the Oncor

Units (or IPO Stock) on any given date, as determined reasonably and in good faith by the board of directors of Oncor and which shall not take into account any minority interest discount and shall not take into account a discount for illiquidity of equity units of Oncor Units (or IPO Stock) or SARs, as applicable in excess of any illiquidity discount applicable to Oncor Units (or IPO Stock) generally.

     “Good Reason” shall mean “Good Reason” as such term may be defined in any employment agreement or change-in-control agreement in effect at the time of termination of employment between the Management Stockholder and the Management Stockholder Employer or any of its Subsidiaries or Affiliates, or, if there is no such employment or change-in-control agreement, “Good Reason” means, with respect to a Management Stockholder: (i) a reduction in the Management Stockholder’s base salary or the Management Stockholder’s annual incentive compensation opportunity (other than a general reduction in base salary or annual incentive compensation opportunities that affects all salaried employees of Oncor equally); (ii) a transfer of the Management Stockholder’s primary workplace by more than thirty-five (35) miles from the current workplace; (iii) a substantial and sustained adverse change in the Management Stockholder’s duties and responsibilities; or (iv) any material breach by the Company or Oncor of this Agreement; provided, however, that any isolated, insubstantial and inadvertent failure by the Company or Oncor that is not in bad faith and is cured within ten (10) Business Days after the Management Stockholder gives the Company or Oncor written notice of any such event set forth above, shall not constitute Good Reason.

     “IPO Stock” shall have the meaning set forth in Section 4(a) hereof.

     “IPO Vehicle” shall have the meaning set forth in Section 1(c) hereof.

     “Management Units” shall have the meaning set forth in the first recital.

     “Management Stockholder” shall have the meaning set forth in the introductory paragraph.

     “Management Stockholder Employer” shall have the meaning set forth in Section 1(c).

     “Management Stockholder Entities” shall mean the Management Stockholder’s Trust, the Management Stockholder and the Management Stockholder’s Estate, collectively.

     “Management Stockholder’s Estate” shall mean the conservators, guardians, executors, administrators, testamentary trustees, legatees or beneficiaries of the Management Stockholder.

     “Management Stockholder’s Trust” shall mean a partnership, limited liability company, corporation, trust, private foundation or custodianship, the beneficiaries of which may include only the Management Stockholder, his or her spouse (or ex-spouse) or his or her lineal descendants (including adopted) or, if at any time after any such Transfer there shall be no then living spouse or lineal descendants, the ultimate beneficiaries of any such trust or to the estate of a deceased beneficiary.

     “Managing Member” shall have the meaning set fourth in Section 1(a).

     “Minority Sale” shall have the meaning set fourth in Section 1(a).

     “Non-Compete Period” shall have the meaning set forth in Section 22(a)(ii) hereof.

     “Oncor” shall have the meaning set forth in the introductory paragraph.

     “Oncor Drag-Along Purchaser” shall have the meaning set forth in Section 4(e) hereof.

     “Oncor Drag Transaction” shall have the meaning set forth in Section 4(e) hereof.

     “Oncor Holdings” shall mean Oncor Electric Delivery Holdings Company LLC, a Delaware limited liability company.

     “Oncor Management Investment LLC” shall have the meaning set forth in the introductory paragraph.

     “Oncor Sale Percentage” shall have the meaning set forth in Section 4(d) hereof.

     “Oncor Units” shall have the meaning set forth in Section 2(a).

     “Parent” shall mean Texas Energy Future Holdings Limited Partnership, a Delaware limited partnership.

     “Parties” shall have the meaning set forth in the introductory paragraph.

     “Permitted Transfer” shall have the meaning set forth in Section 3(a).

     “Person” shall mean “person,” as such term is used for purposes of Section 13(d) or 14(d) of the Exchange Act.

     “Program” shall have the meaning set forth in the first recital.

     “Public Offering” shall mean the sale of units or shares, as applicable, of Oncor, the Company, an IPO Vehicle or EFH Corp. to the public subsequent to the date hereof pursuant to a registration statement under the Act which has been declared effective by the SEC (other than a registration statement on Form S-4, S-8 or any other similar form).

     “Purchased Units” shall have the meaning set forth in the first recital.

     “Qualified Public Offering” shall mean any firm underwritten public offering of shares of stock or equity units of Oncor (or IPO Stock) or the Company (as applicable, the “Subject Stock”) (or series of related offerings) pursuant to an effective registration statement under the Act (other than a registration statement on Form S-4 or S-8 or any other similar form) pursuant to which at least 25% of the outstanding shares or units of the Subject Stock are or have been sold to the public.

     “Redemption Notice” shall have the meaning set forth in Section 5(b) hereof.

     “Redemption Period” shall have the meaning set forth in Section 5(a) hereof.

     “Registration Rights Agreement” shall have the meaning set forth in Section 9 hereof.

     “Related Entity” means Oncor Holdings or any current or future Affiliate of Oncor Holdings which holds a direct equity interest in Oncor, other than Oncor Management Investment LLC.

     “Repurchase Calculation Date” shall mean (i) prior to the occurrence of a Public Offering of the applicable security, the last day of the month preceding the month in which date of repurchase occurs, and (ii) on and after the occurrence of a Public Offering of the applicable security, last date of trading of the applicable Units immediately preceding the date of repurchase on which there was a closing trading price for the applicable Units.

     “Repurchase Notice” shall have the meaning set forth in Section 6(c) hereof.

     “Repurchase Price” or “Redemption Price” shall mean the amount to be paid in respect of the Units and Stock Appreciation Rights to be purchased by the Company, Oncor or an IPO Vehicle pursuant to Section 5 and Section 6, as applicable.

     “Request” shall have the meaning set forth in Section 4(g) hereof.

     “Restricted Group” shall mean, collectively, EFH Corp. and any of its direct or indirect Subsidiaries, the members of the Sponsor Group and their respective Affiliates.

     “Retirement” shall mean the Management Stockholder’s retirement at age 55 or over after having been employed by EFH, Oncor, an IPO Vehicle, or any of their Subsidiaries for at least ten (10) consecutive years (with at least five consecutive years of employment with Oncor following October 10, 2007); provided that such ten (10) consecutive years may include years of service with a service provider to any of the foregoing entities so long as substantially all of the Management Stockholder’s work with such service provider related to such entity.

     “Sale Participation Agreement” shall mean that certain sale participation agreement entered into by and between the Management Stockholder and Oncor Holdings, dated as of the date hereof.

     “Section 6(a) Call Event” shall have the meaning set forth in Section 6(a) hereof.

     “Section 6(b) Call Event” shall have the meaning set forth in Section 6(b) hereof.

     “Section 6(b)(ii) Call Event” shall have the meaning set forth in Section 6(b) hereof.

     “SEC” shall mean the Securities and Exchange Commission.

     “Sponsor Group” shall investment funds affiliated with Kohlberg Kravis Roberts & Co. L.P., TPG Capital, L.P. and Goldman, Sachs & Co.

     “Stock Appreciation Rights” shall have the meaning set forth in the first recital.

     “Stock Appreciation Rights Agreement” shall have the meaning set forth in the first recital.

     “Stock Appreciation Rights Plan” shall have the meaning set forth in the first recital.

     “Subject Stock” has the meaning set forth in the definition of Qualified Public Offering.

     “Subsidiaries” shall mean, with respect to any Person, any corporation or other entity in an unbroken chain of corporations or other entities beginning with such Person, if each of the corporations or other entities, or group of commonly controlled corporations or other entities, other than the last corporation or other entity in the unbroken chain then owns stock or other stock interests possessing 50% or more of the total combined voting power of all classes of stock or other stock interests in one of the other corporations or other entities in such chain.

     “Transfer” shall have the meaning set forth in Section 2(a) hereof.

     “Units” shall have the meaning set forth in Section 2(a) hereof.

          8. The Company’s and Oncor’s Representations and Warranties and Covenants.

          (a) Each of the Company and Oncor represent and warrant to the Management Stockholder that this Agreement has been duly authorized, executed and delivered by each of the Company and Oncor, respectively, and is enforceable against the Company and Oncor in accordance with its terms. Each of the Company and Oncor, represents and warrants to the Management Stockholder that the applicable Units issued by such entity, when issued and delivered in accordance with the terms hereof and the other agreements contemplated hereby, will be duly and validly issued, fully paid and nonassessable.

          (b) If the Company, Oncor or an IPO Vehicle becomes subject to the reporting requirements of Section 12 of the Exchange Act, the Company, Oncor or such IPO Vehicle, as applicable, will file the reports required to be filed by it under the Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder, to the extent required from time to time to enable the Management Stockholder to sell the applicable Units, subject to compliance with the provisions hereof (including requirements of the Company, Oncor or such IPO Vehicle) without registration under the Exchange Act within the limitations of the exemptions provided by (A) Rule 144 under the Act, as such Rule may be amended from time to time, or (B) any similar rule or regulation hereafter adopted by the SEC. Notwithstanding anything contained in this Section 8(b), the Company, Oncor or such IPO Vehicle may de-register under Section 12 of the Exchange Act if it is then permitted to do so pursuant to the Exchange Act and the rules and regulations thereunder and, in such circumstances, shall not be required hereby to file any reports which may be necessary in order for Rule 144 or any similar rule or regulation under the Act to be available. Nothing in this Section 8(b) shall be deemed to limit in any manner the restrictions on Transfers of Units contained in this Agreement.

          9. Registered Sales. After an initial Public Offering, in the event of a sale of Units by EFH Corp. or any of its Subsidiaries (such Person(s), the “EFH Seller”) in a Public Offering such that, if the applicable Units were EFH Common Stock and the Management Stockholder were a party to the Registration Rights Agreement entered into by and among EFH Corp. and the Sponsor Group members party thereto (the “Registration Rights Agreement”), the Management Stockholder would be entitled to piggy-back

registration rights, then the Company and Oncor shall release, subject to applicable law, from the transfer restrictions contained in Section 3(a) hereof a number of the applicable Units, held by the Management Stockholder equal to the number of the applicable Units then held by the Management Stockholder Entities, multiplied by a fraction, the numerator of which is the aggregate number of the applicable Units being registered and sold in such Public Offering by the EFH Seller and the denominator of which is the aggregate number of the applicable Units owned by EFH Corp. and its Subsidiaries.

          10. Rights to Negotiate Repurchase Price. Nothing in this Agreement shall be deemed to restrict or prohibit the Company, Oncor or an IPO Vehicle from purchasing, redeeming, repurchasing or otherwise acquiring for value Units or Stock Appreciation Rights from the Management Stockholder, at any time, upon such terms and conditions, and for such price, as may be mutually agreed upon in writing between the Parties, whether or not at the time of such purchase, redemption, repurchase or acquisition circumstances exist which specifically grant the Company, Oncor or an IPO Vehicle the right to purchase, or the Management Stockholder the right to sell, Units or any Stock Appreciation Rights under the terms of this Agreement.

          11. Notice of Change of Beneficiary. Immediately prior to any Transfer of Units to a Management Stockholder’s Trust, the Management Stockholder shall provide the Company, Oncor and, if applicable, any IPO Vehicle with a copy of the instruments creating the Management Stockholder’s Trust and with the identity of the beneficiaries of the Management Stockholder’s Trust. The Management Stockholder shall notify the Company, Oncor and, if applicable, any IPO Vehicle as soon as practicable prior to any change in the identity of any beneficiary of the Management Stockholder’s Trust.

          12. Recapitalizations, etc. The provisions of this Agreement shall apply, to the full extent set forth herein with respect to the Units or the Stock Appreciation Rights, to any and all units or shares of capital stock of the Company, Oncor and any IPO Vehicle or any capital stock, partnership units or any other security evidencing ownership interests in any successor or assign of the Company, Oncor or any IPO Vehicle (whether by merger, consolidation, sale of assets or otherwise) which may be issued in respect of, in exchange for, or substitution of the Units or the Stock Appreciation Rights by reason of any dividend, split, reverse split, combination, recapitalization, liquidation, reclassification, merger, consolidation or otherwise.

          13. Management Stockholder’s Employment by Oncor. Nothing contained in this Agreement (a) obligates the Company, Oncor, any other Management Stockholder Employer or any of their respective Affiliates to employ the Management Stockholder in any capacity whatsoever or (b) prohibits or restricts Oncor or any other Management Stockholder Employer or any of their respective Affiliates from terminating the employment of the Management Stockholder at any time or for any reason whatsoever, with or without Cause, and the Management Stockholder hereby acknowledges and agrees that none of the Company, Oncor, any other Management Stockholder Employer or any other person has made any representations or promises whatsoever to the Management Stockholder concerning the Management Stockholder’s employment or continued employment by the Company, Oncor, any other Management Stockholder Employer or any of their respective Affiliates.

          14. Binding Effect. The provisions of this Agreement shall be binding upon and accrue to the benefit of the Parties hereto and their respective heirs, legal

representatives, successors and assigns. In the case of a transferee permitted under clauses (2), (3) or (4) of Section 2(a) or clauses (ii) and (v) of Section 3(a) hereof, such transferee shall be deemed the Management Stockholder hereunder; provided, however, that no transferee (including without limitation, transferees referred to in Section 2(a) or Section 3(a) hereof) shall derive any rights under this Agreement unless and until such transferee has delivered to the Company, Oncor or any applicable IPO Vehicle a valid undertaking and becomes bound by the terms of this Agreement. No provision of this Agreement is intended to or shall confer upon any Person other than the Parties any rights or remedies hereunder or with respect hereto.

          15. Amendment. This Agreement may be amended by the Company, Oncor or any applicable IPO Vehicle at any time; provided that any amendment (i) that materially disadvantages the Management Stockholder shall not be effective unless and until the Management Stockholder has consented thereto in writing and (ii) that disadvantages the Management Stockholders in more than a de minimis way but less than a material way shall require the consent of Management Stockholders holding a majority of the equity interests held by the Management Stockholders; and provided further that no amendment shall be effective without the consent of Oncor Holdings.

          16. Closing. Except as otherwise provided herein, the closing of each purchase and sale of Units or redemption of Stock Appreciation Rights pursuant to this Agreement shall take place at the principal office of the Company, Oncor or any applicable IPO Vehicle, as applicable on the tenth Business Day following delivery of the notice by any Party to the another of its exercise of the right to purchase or sell such Units or redeem such Stock Appreciation Rights hereunder; provided that, notwithstanding anything to the contrary contained herein, payment with respect to any Transfer of Units by the Company shall in no event be due earlier than on or about the second business day after the date of payment of the next regular quarterly dividend paid by Oncor following the date of Transfer.

          17. Applicable Law; Jurisdiction; Arbitration; Legal Fees.

          (a) The laws of the State of Texas applicable to contracts executed and to be performed entirely in such state shall govern the interpretation, validity and performance of the terms of this Agreement.

          (b) In the event of any controversy among the parties hereto arising out of, or relating to, this Agreement which cannot be settled amicably by the parties, such controversy shall be finally, exclusively and conclusively settled by mandatory arbitration conducted expeditiously in accordance with the American Arbitration Association rules by a single independent arbitrator. Such arbitration process shall take place in Dallas, Texas. The decision of the arbitrator shall be final and binding upon all parties hereto and shall be rendered pursuant to a written decision, which contains a detailed recital of the arbitrator’s reasoning. Judgment upon the award rendered may be entered in any court having jurisdiction thereof.

          (c) Notwithstanding the foregoing, the Management Stockholder acknowledges and agrees that the Company, Oncor, any IPO Vehicle any Management Stockholder Employer, their Subsidiaries, the Sponsor Group and any of their respective Affiliates shall be entitled to injunctive or other relief in order to enforce the covenant not to compete, covenant not to solicit and/or confidentiality covenants as set forth in Section 22(a)

of this Agreement.

          (d) In the event of any arbitration or other disputes with regard to this Agreement or any other document or agreement referred to herein, each Party shall pay its own legal fees and expenses, unless otherwise determined by the arbitrator.

          18. Assignability of Certain Rights by the Company and Oncor. The Company, Oncor or any IPO Vehicle shall have the right to assign any or all of its rights or obligations to purchase, repurchase Units or redeem Stock Appreciation Rights pursuant to Sections 4, 5 and 6 hereof; provided, however, that no such assignment shall relieve the Company, Oncor or such IPO Vehicle from its obligations thereunder.

          19. Miscellaneous.

          (a) In this Agreement all references to “dollars” or “$” are to United States dollars and the masculine pronoun shall include the feminine and neuter, and the singular the plural, where the context so indicates.

          (b) If any provision of this Agreement shall be declared illegal, void or unenforceable by any court of competent jurisdiction, the other provisions shall not be affected, but shall remain in full force and effect.

          20. Withholding.

          (a) The Company, Oncor, any IPO Vehicle and their respective Subsidiaries shall each have the right to deduct from any cash payment made under this Agreement to the applicable Management Stockholder Entities any federal, state or local income or other taxes required by law to be withheld with respect to such payment, if applicable.

          (b) To the extent permitted under applicable tax laws, each of the Company, Oncor and any IPO Vehicle will dividend or distribute to the Management Stockholder a cash dividend equivalent payment sufficient to satisfy any minimum withholding taxes associated with Management Stockholder’s Units. For Stock Appreciation Rights for which the actual equity value has exceeded the Base Price after taking into account dividends, the payment of these dividends will occur on the earlier of a distribution event as set forth in Section 409A of the Code or the exercise of the Stock Appreciation Right.

          21. Notices. All notices and other communications provided for herein shall be in writing. Any notice or other communication hereunder shall be deemed duly given (i) upon electronic confirmation of facsimile, (ii) one Business Day following the date sent when sent by overnight delivery and (iii) five (5) Business Days following the date mailed when mailed by registered or certified mail return receipt requested and postage prepaid, in each case as follows:

          (a) If to the Company or Oncor, to it at the following address:

Oncor Electric Delivery Company LLC
Oncor Management Investment LLC

c/o Oncor Electric Delivery Company LLC
Energy Plaza
1601 Bryan Street
Dallas, Texas ###-###-####
Facsimile:     (214)  ###-###-####
Attention:     Legal Department, 22nd Floor

with a copy to:

Baker & McKenzie LLP
One Prudential Plaza
130 East Randolph Drive
Chicago, Illinois 60601
Facsimile:     (312)  ###-###-####
Attention:     James P. O’Brien

and

Simpson Thacher & Bartlett LLP
425 Lexington Avenue
New York, New York 10017
Attention: Alvin H. Brown, Esq.
                 Andrew W. Smith, Esq.

Facsimile: (212)  ###-###-####

          (b) If to the Management Stockholder, to the Management Stockholder at the address set forth below under the Management Stockholder’s signature; or at such other address as either party shall have specified by notice in writing to the other.

          22. Confidential Information; Covenant Not to Compete; Covenant Not to Solicit.

          (a) In consideration of the Company and Oncor entering into this Agreement with the Management Stockholder and hereby promising and committing themselves to provide the Management Stockholder with Confidential Information and/or specialized training after the Management Stockholder executes this Agreement, unless there exists any covenant that pertains to the same subject matter as set forth in this Section 22 in any employment agreement or change in control agreement in effect at the time of termination of employment between the Management Stockholder and the Management Stockholder Employer or its Affiliates in which case such covenants shall supersede the covenants contained in this Section 22; then the Management Stockholder shall be subject to the covenants contained in this Section 22. Subject to the preceding sentence, the Management Stockholder shall not, directly or indirectly:

     (i) at any time during or after the Management Stockholder’s employment with the Management Stockholder Employer, disclose any Confidential Information pertaining to the business of the Company, Oncor, any IPO Vehicle, any other Management Stockholder Employer or any of their Subsidiaries or the Sponsor Group

or any of their respective Affiliates, except when required to perform his or her duties to the Management Stockholder Employer, by law or judicial process;

     (ii) at any time during the Management Stockholder’s employment with the Management Stockholder Employer and for a period of twelve (12) months thereafter (the “Non-Compete Period”), directly or indirectly, act as a proprietor, investor, director, officer, employee, substantial stockholder, consultant, or partner in any Competing Business in Texas or any other geographic area in which EFH Corp., Oncor Holdings, Oncor, any IPO Vehicle or any of their Subsidiaries operates or conducts business; or

     (iii) at any time during the Management Stockholder’s employment with the Management Stockholder Employer and for a period of twelve (12) months thereafter, directly or indirectly (A) solicit customers or clients of EFH Corp., Oncor, any IPO Vehicle or any of their Subsidiaries to terminate their relationship with EFH Corp., Oncor, any IPO Vehicle or any of their Subsidiaries or otherwise solicit such customers or clients to compete with any businesses of EFH Corp., Oncor, any IPO Vehicle or any of their Subsidiaries, or (B) solicit or offer employment to any person who is, or has been at any time during the twelve (12) months immediately preceding the termination of the Management Stockholder’s employment employed by EFH Corp., Oncor, any IPO Vehicle or any of their Subsidiaries;

provided that in each of (ii) and (iii) above, such restrictions shall not apply with respect to any member of the Sponsor Group or any of its Affiliates that is not engaged in any business that competes, directly or indirectly, with EFH Corp., Oncor, any IPO Vehicle or any of their Subsidiaries. If the Management Stockholder is bound by any other agreement with EFH Corp., Oncor, any IPO Vehicle, the Company or any of their respective Subsidiaries regarding the use or disclosure of Confidential Information, the provisions of this Agreement shall be read in such a way as to further restrict and not to permit any more extensive use or disclosure of Confidential Information. Notwithstanding the foregoing, for the purposes of Section 22(a)(ii), (A) the Management Stockholder may, directly or indirectly own, solely as an investment, securities of any Person engaged in the business of EFH Corp., Oncor, any IPO Vehicle, the Company or any of their respective Subsidiaries or their respective Affiliates which are publicly traded on a national or regional stock exchange or quotation system or on the over-the-counter market if the Management Stockholder (I) is not a controlling person of, or a member of a group which controls, such person and (II) does not, directly or indirectly, own 5% or more of any class of securities of such Person (B) the Non-Compete Period shall not be triggered by any exercise of tag-along rights under the Sale Participation Agreement, Drag Transaction, EFH Drag Transaction, Oncor Drag Transaction, or transaction pursuant to Section 4(b) or 4(e) that may occur after the date hereof.

          (b) Notwithstanding clause (a) above, if at any time a court holds that the restrictions stated in such clause (a) are unreasonable or otherwise unenforceable under circumstances then existing, the parties hereto agree that the maximum period, scope or geographic area determined to be reasonable under such circumstances by such court will be substituted for the stated period, scope or area. Because the Management Stockholder’s services are unique and because the Management Stockholder has had access to Confidential

Information, the parties hereto agree that money damages will be an inadequate remedy for any breach of this Agreement (except with respect to any violation of provisions of Section 22(a)(ii)). In the event of a breach or threatened breach of this Agreement, the Company or its successors or assigns may, in addition to other rights and remedies existing in their favor, apply to any court of competent jurisdiction for specific performance and/or injunctive relief in order to enforce, or prevent any violations of, the provisions hereof (without the posting of a bond or other security).

          (c) In the event that the Management Stockholder engages in activity giving rise to a Section 6(b)(ii) Call Event or breaches any of the provisions of Sections 22(a)(ii) or 22(a)(iii), the Management Stockholder shall be required to pay to the Company, Oncor or the IPO Vehicle any amounts actually paid (including any dividends) to him or her or otherwise received in respect of any repurchase or disposition of any Stock Appreciation Rights, Management Units, Oncor Units or IPO Stock held by such Management Stockholder; provided that, in the event the Management Stockholder engages in activity giving rise to a Section 6(b)(ii) Call Event (to the extent the provisions of Section 6(b)(iv) are applicable) or breaches any of the provisions of Section 22(a)(ii), the provisions of this Section 22(c) shall be the Company’s, Oncor’s and/or the IPO Vehicle’s sole remedy.

          23. Voting. The Management Stockholder acknowledges that the Managing Member, on behalf of the Company, shall have the exclusive right to vote (or cause to vote) or execute (or cause to execute) consents with respect to Management Units and the Oncor Units held by the Company, directly or indirectly, on any matter to be voted upon at any meeting of the holders of Oncor Units, or in connection with any proposed action by written consent of the holders of Oncor Units; provided that, with respect to votes or executions of consents attributed to Oncor Units held by the Company, each Management Stockholder shall have the right to direct the Managing Member to vote (or cause to vote) or execute (or cause to execute) consents attributable to Oncor Units equal to the total Oncor Units held by the Company multiplied by a percentage calculated by dividing (x) the aggregate number of Management Units held by such Management Stockholder by (y) the aggregate number of Management Units issued and outstanding on such date if such Management Stockholder provides the Managing Member a written indication of such direction no less than 10 Business Days prior to such vote or execution, unless some lesser time period is consented to by the Managing Member; provided further that, the forgoing proviso shall not apply to any vote at a regular or special meeting of the members of Oncor for the express purpose of approving any Change in Control transaction or agreement and subject to, and to the extent permitted, by the laws of the State of Texas, each Management Stockholder hereby irrevocably appoints Oncor Holdings and any authorized representatives and designees thereof as its lawful proxy and attorney-in-fact to exercise with full power in such Management Stockholder’s name and on its behalf any right that Management Stockholder has to vote on such matter in respect of its indirect interest in Oncor through its Management Units and in respect of any other Oncor Units that it directly holds. If voting under any such proxy, Oncor Holdings, and any authorized representatives and designees thereof, shall vote under such proxy on behalf of each such Management Stockholder in the same manner as Oncor Holdings votes any outstanding membership interests in Oncor owned by it at any such regular or special meeting of the stockholders of Oncor for the express purpose of approving any Change in Control transaction or agreement. This proxy is irrevocable and is coupled with an interest and shall not be terminable as long as this Agreement remains effective among the parties hereto, their successors, transferees and assigns

and, if such Management Stockholder is a natural person, shall not terminate on the disability or incompetence of such Management Stockholder. Oncor is hereby requested and directed to honor this proxy upon its presentation by Oncor Holdings and any authorized representatives and designees thereof, without any duty of investigation whatsoever on the part of Oncor. Each such Management Stockholder agrees that Oncor, and Oncor’s secretary shall not be liable to such Management Stockholder for so honoring this proxy. This Section 23 shall terminate and be of no further force or effect upon the later of (x) October 10, 2012 or (y) the consummation of a Qualified Public Offering of Oncor.

          24. IPO Exchange. At any time after the date hereof, in connection with a Public Offering of an IPO Vehicle, Oncor may determine that it is in the best interests of Oncor to exchange any Oncor Units held by the Company and the Management Stockholder for IPO Stock. In such event, the Management Stockholder agrees to exchange any Oncor Units held by it for IPO Stock; provided that, the rights attaching to such IPO Stock shall be substantially equivalent to the rights that attached to the Oncor Units previously held by such Management Stockholder.

          25. Liability. Notwithstanding anything contained herein or otherwise, EFH Corp., Oncor Holdings and Parent are not parties to this agreement and shall bear no liability, nor make any representations and warranties herein.

          26. Final Agreement. This agreement constitutes the final agreement between the parties with respect to the matters contained herein and amends, restates and supercedes any and all prior written or oral management stockholder agreements.

[Signatures on next page.]

     IN WITNESS WHEREOF, the Parties have executed this Agreement as of                      , 2009, to be effective as of November 5, 2008.

		ONCOR ELECTRIC DELIVERY COMPANY LLC
		By:
		Name:
		Title:
		ONCOR MANAGEMENT INVESTMENT LLC
		By: Oncor Electric Delivery Company LLC, its managing member
		By:
		Name:
		Title:

		MANAGEMENT STOCKHOLDER:
		Name:
		ADDRESS:
		o The above-signed represents that he/she is an “accredited investor” as defined in Rule 501(a) of Regulation D, as amended, under the Act (the number of Purchased Units available to be acquired by Management Stockholders who are not accredited Investors may be limited and accordingly Purchased Units offered to those Management Stockholders may be subject to mandatory cutbacks and reduction).

Schedule I

Purchased Units

Number of Purchased Units (up to ___) (to be purchased at the Base Price):                     

Base Price: $10.00